Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae
US7238669B2 · kind B2 · utility
10Cited by
3References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2003 |
| Grant date | Jul 3, 2007 |
| Priority date | — |
| Expiry date | Mar 16, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.